EyePod

In this podcast, experts Mary Qiu, MD; Paul Singh, MD; and Danica J. Marrelli, OD, FAAO; discuss interventional glaucoma. This more proactive management approach aims to minimize the challenges of topical glaucoma management with the earlier use of procedures.

In this podcast, experts Francis Mah, MD; and Amy Nau, OD, FAAO, Dipl, CCLRT; discuss how to identify neurotrophic keratitis in practice, highlighting indications for corneal sensitivity testing based on patient history and examination findings. Faculty will also examine how to stage and treat neurotrophic keratitis once diagnosed.

No description provided.

Eichenbaum Acorns is an editorially independent series powered by Modern Retina® and hosted by David A. Eichenbaum, MD, FASRS, partner and director of research at Retina Vitreous Associates of Florida in Tampa. This Q&A-style article and podcast series explore the overlooked corners of the retina specialist profession through candid conversations with thought leaders. Eichenbaum is the German translation for oak tree, and the aim of this series is to plant acorns of insight that grow into oaks of understanding.In this installment, Eichenbaum chats with Jordan M. Graff, MD, FACS, of Barnet Dulaney Perkins Eye Center in Phoenix, Arizona, to discuss the realities of early adoption in retina care. Graff’s experience with the port delivery system (PDS) (Susvimo; Genentech), first as an investigator and later as one of the most active commercial utilizers in the US, provides insight into the opportunities and challenges of early adoption. He has navigated both the initial excitement of innovation and the realities of setbacks, including Genentech’s October 2022 voluntary recall following septum dislodgement issues. With the July 2024 reintroduction of a revised product, Graff offers a perspective on resuming adoption post-recall.

In this inaugural episode of the Ophthalmology Times® “Beyond The Walls” podcast, host Deborah Ristvedt, DO, of Vance Thompson Vision, welcomes Marguerite B. McDonald, MD, FACS, a trailblazer in refractive surgery, dry eye research, and ophthalmic leadership. The conversation traces McDonald’s journey from childhood experiences with severe myopia to her pioneering role in laser vision correction, as well as ongoing research and advice for the next generation of eye care professionals. McDonald is clinical professor of ophthalmology at NYU Langone Medical Center in New York and Tulane University Health Sciences Center in New Orleans, and in practice at OCLI Vision in Oceanside, NY.

In this podcast, experts John D. Gelles, OD, FAAO, FIAOMC, FCLSA, FSLS, FBCLA; and John Hovanesian, MD, FACS; discuss the importance of comprehensive strategies when performing corneal sensitivity testing in patients suspected of having neurotrophic keratitis (NK).

Thyroid eye disease (TED), a rare autoimmune condition, can be sight-threatening, debilitating, and disfiguring, severely impacting patients’ quality of life and daily functioning. Traditional management approaches for TED have centered on immunomodulatory therapy and surgical interventions. In January 2020, the US Food and Drug Administration (FDA) approved teprotumumab, the first therapy specifically indicated for TED. As treatment options evolve, there is an increasing need for a patient-centered, multidisciplinary approach, which is essential to address individual patient needs throughout the disease course. This PER On Air Ophthalmology Times podcast provides an in-depth review of some of the key highlights from a satellite symposium that took place at the Envision Summit 2025 meeting in February 2025. This unique and engaging activity focuses on the practical aspects of managing patients with thyroid eye disease, putting recent clinical trial data into clinical context. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.

Geographic atrophy, an advanced stage of age-related macular degeneration, is a significant cause of vision loss. Given the progressive nature of geographic atrophy and its significant impact on quality of life, educating health care professionals about the disease burden, diagnostic strategies, and evolving management strategies is essential.This PER On-Air Ophthalmology Times podcast provides an in-depth review of some of the key highlights from the Envision Summit 2025 meeting, held in February 2025. This unique and engaging activity focuses on the practical aspects of managing patients with geographic atrophy, putting recent clinical trial data into clinical context. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.